Organization | BioActor

BioActor Report issue

For profit Phase 2

Founded: Maastricht Netherlands (2005)

Status: No NME R&D (2005)

Organization Overview

First Clinical Trial

2008

NCT00789425

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Bioactor | BioActor | BioActor B.V.

Active Ingredients

Drugs in Phase 2 Trials (2)

olive (2 trials)

wheat (1 trial)

Drugs in Other Trials (10)

arabinoxylan (1 trial)

aronia extract (2 trials)

beta-glucans (1 trial)

cellulose (1 trial)

citrus extract (1 trial)

citrus flavonoid (1 trial)

guarana (1 trial)

orange (1 trial)

pomegranate (2 trials)

sweet orange peel tincture (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Bone Diseases, Metabolic (Phase 2)

Common Cold (Phase 2)

Communicable Diseases (Phase 2)

Infections (Phase 2)

Osteoporosis (Phase 2)

Respiratory Tract Infections (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 10
# of Trial APIs: 12